Related Experiment Video
Updated: May 23, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses
1Department of Pathology, School of Medicine, Kyung Hee University, Seoul, Korea.
Abstract:
p53 is a key regulator of cell growth and death by controlling cell cycle progression and apoptosis under conditions of stress such as DNA damage or oncogenic stimulation. As these processes are critical for cell function and inhibition of tumor development, p53 regulatory pathways are strictly monitored in cells. Recently, it was recognized that nucleolar proteins, including nucleophosmin/B23, ribosomal protein L11, and alternate reading frame (ARF), form the nucleolus-ARF-murine double minute 2 (MDM2) axis in p53 regulatory pathways, which increases p53 stability by suppressing the activity of MDM2. In this work, we show that nucleolar protein glioma tumor-suppressor candidate region gene 2 (GLTSCR2) translocates to the nucleoplasm under ribosomal stress, where it interacts with and stabilizes p53 and inhibits cell cycle progression without the involvement of the major upstream p53 regulator, ARF. Furthermore, ectopic expression of GLTSCR2 significantly suppressed growth of cancer cells in a xenograft animal model via p53-dependent pathway. Our data identify GLTSCR2 as a new member of the nucleolus-nucleoplasmic axis for p53 regulation. ARF-independent direct regulation of p53 by GLTSCR2 may be a key mechanism and therapeutic target for cell death or growth inhibition when nucleolus-ARF-p53 pathways are inactivated by genetic or epigenetic modifications of ARF, which are the second most common types of genetic change observed in human cancers.
Insights
Glioma tumor-suppressor candidate region gene 2 (GLTSCR2) stabilizes p53 protein, inhibiting cancer cell growth independently of ARF. This discovery offers a new therapeutic target for cancers with altered p53 pathways.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- p53 is a critical regulator of cell cycle and apoptosis, essential for preventing tumor development.
- The nucleolus-ARF-MDM2 axis is a known pathway for p53 regulation, enhancing p53 stability.
- Alterations in ARF are common in human cancers, impacting p53 pathway function.
Purpose of the Study:
- To investigate the role of nucleolar protein GLTSCR2 in p53 regulation.
- To identify novel mechanisms for p53 stabilization and cell cycle inhibition.
- To explore GLTSCR2 as a potential therapeutic target in cancer.
Main Methods:
- Studied the translocation of GLTSCR2 under ribosomal stress.
- Investigated the interaction between GLTSCR2 and p53.
- Assessed the effect of GLTSCR2 on cell cycle progression.
- Evaluated GLTSCR2's impact on cancer growth in a xenograft model.
Main Results:
- GLTSCR2 translocates to the nucleoplasm under ribosomal stress.
- GLTSCR2 interacts with and stabilizes p53, inhibiting cell cycle progression independently of ARF.
- Ectopic GLTSCR2 expression suppressed cancer cell growth in vivo via a p53-dependent pathway.
Conclusions:
- GLTSCR2 is a novel nucleolar-nucleoplasmic regulator of p53.
- ARF-independent regulation of p53 by GLTSCR2 presents a potential therapeutic strategy for cancers with ARF pathway inactivation.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Stringent Response in E. coli
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Nucleolus

